Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation

Cell Death and Differentiation

Volumn 19, Issue 8, 2012, Pages 1381-1389

  Hallenborg, P ^a,b   Feddersen, S ^a   Francoz, S ^c   Murano, I ^d   Sundekilde, U ^a   Petersen, R K ^b   Akimov, V ^a   Olson, M V ^e   Lozano, G ^e   Cinti, S ^d   Gjertsen, B T ^f   Madsen, L ^b,g   Marine, J C ^c   Blagoev, B ^a   Kristiansen, K ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF BERGEN   (Norway)

^g INSTITUTE OF MARINE RESEARCH   (Norway)

Author keywords

adipogenesis; CREB; Crtc2; Mdm2

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN TRANSCRIPTION COACTIVATOR 2; PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL FATE; EX VIVO STUDY; GENE SWITCHING; MOLECULAR STABILITY; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; PRIORITY JOURNAL; TRANSACTIVATION;

ADIPOCYTES; ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION REGULATION; MICE; MUSCLE CELLS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 84863727020     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2012.15     Document Type: Article

References (41)

1. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006; 4: 263-273. (Pubitemid 44430910)
2. Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J 1997; 16: 7432-7443. (Pubitemid 28010503)
3. Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008; 22: 2941-2952.
4. Reusch JE, Colton LA, Klemm DJ. CREB activation induces adipogenesis in 3T3-L1 cells. Mol Cell Biol 2000; 20: 1008-1020. (Pubitemid 30044238)
5. Zhang JW, Klemm DJ, Vinson C, Lane MD. Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis. J Biol Chem 2004; 279: 4471-4478. (Pubitemid 38199037)
6. Fox KE, Fankell DM, Erickson PF, Majka SM, Crossno Jr JT, Klemm DJ. Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. J Biol Chem 2006; 281: 40341-40353. (Pubitemid 46041839)
7. Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S et al. The CREB coactivator TORC2 functions as a calcium-and cAMP-sensitive coincidence detector. Cell 2004; 119: 61-74. (Pubitemid 39349320)
8. Xu W, Kasper LH, Lerach S, Jeevan T, Brindle PK. Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. EMBO J 2007; 26: 2890-2903. (Pubitemid 46975783)
9. Ravnskjaer K, Kester H, Liu Y, Zhang X, Lee D, Yates III JR et al. Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J 2007; 26: 2880-2889. (Pubitemid 46975772)
10. Jones SN, Roe AE, Donehower LA, Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995; 378: 206-208.
11. Montes de Oca LR, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995; 378: 203-206.
12. Chavez-Reyes A, Parant JM, Amelse LL, de Oca Luna RM, Korsmeyer SJ, Lozano G. Switching mechanisms of cell death in mdm2-and mdm4-null mice by deletion of p53 downstream targets. Cancer Res 2003; 63: 8664-8669. (Pubitemid 38064041)
13. Marine JC, Lozano G. Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 2010; 17: 93-102.
14. Toledo F, Wahl GM. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006; 6: 909-923. (Pubitemid 44862676)
15. Sirvent N, Coindre JM, Maire G, Hostein I, Keslair F, Guillou L et al. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol 2007; 31: 1476-1489. (Pubitemid 47482460)
16. Perez-Mancera PA, Sanchez-Garcia I. Understanding mesenchymal cancer: the liposarcoma-associated FUS-DDIT3 fusion gene as a model. Semin Cancer Biol 2005; 15: 206-214.
17. Berberich SJ, Litteral V, Mayo LD, Tabesh D, Morris D. Mdm-2 gene amplification in 3T3-L1 preadipocytes. Differentiation 1999; 64: 205-212. (Pubitemid 29233980)
18. Brown DR, Thomas CA, Deb SP. The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis. EMBO J 1998; 17: 2513-2525. (Pubitemid 28221187)
19. Fakharzadeh SS, Trusko SP, George DL. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 1991; 10: 1565-1569. (Pubitemid 21905621)
20. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 2004; 119: 861-872. (Pubitemid 40017691)
21. Fiddler TA, Smith L, Tapscott SJ, Thayer MJ. Amplification of MDM2 inhibits MyoDmediated myogenesis. Mol Cell Biol 1996; 16: 5048-5057. (Pubitemid 26272159)
22. Guo CS, Degnin C, Fiddler TA, Stauffer D, Thayer MJ. Regulation of MyoD activity and muscle cell differentiation by MDM2, pRb, and Sp1. J Biol Chem 2003; 278: 22615-22622. (Pubitemid 36830319)
23. Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. Krox20 stimulates adipogenesis via C/EBPbeta-dependent and-independent mechanisms. Cell Metab 2005; 1: 93-106. (Pubitemid 43960592)
24. Cheung KJ, Tzameli I, Pissios P, Rovira I, Gavrilova O, Ohtsubo T et al. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab 2007; 5: 115-128. (Pubitemid 46187493)
25. Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, Fujiu K et al. Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab 2005; 1: 27-39. (Pubitemid 43960584)
26. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991; 5: 1538-1552. (Pubitemid 21906060)
27. Aubert J, Saint-Marc P, Belmonte N, Dani C, Né grel R, Ailhaud G. Prostacyclin IP receptor up-regulates the early expression of C/EBP[beta] and C/EBP[delta] in preadipose cells. Mol Cell Endocrinol 2000; 160: 149-156. (Pubitemid 30129061)
28. Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K et al. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac-and cAMP-dependent protein kinase-dependent processes. Mol Cell Biol 2008; 28: 3804-3816. (Pubitemid 351732914)
29. Tang T, Gao MH, Miyanohara A, Hammond HK. Galphaq reduces cAMP production by decreasing Galphas protein abundance. Biochem Biophys Res Commun 2008; 377: 679-684.
30. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 2005; 102: 4459-4464. (Pubitemid 40397134)
31. Sordella R, Jiang W, Chen GC, Curto M, Settleman J. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 2003; 113: 147-158. (Pubitemid 36514967)
32. Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, Satoh T et al. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J 2006; 273: 2730-2748.
33. Altarejos JY, Goebel N, Conkright MD, Inoue H, Xie J, Arias CM et al. The Creb1 coactivator Crtc1 is required for energy balance and fertility. Nat Med 2008; 14: 1112-1117.
34. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998; 26: 362-367. (Pubitemid 28295292)
35. Uebi T, Tamura M, Horike N, Hashimoto YK, Takemori H. Phosphorylation of the CREBspecific coactivator TORC2 at Ser(307) regulates its intracellular localization in COS-7 cells and in the mouse liver. Am J Physiol Endocrinol Metab 2010; 299: E413-E425.
36. Liu Y, Dentin R, Chen D, Hedrick S, Ravnskjaer K, Schenk S et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 2008; 456: 269-273.
37. Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell 1998; 2: 405-415. (Pubitemid 128381293)
38. Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, Rinon A et al. P53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLoS One 2008; 3: e3707.
39. McMasters KM, Montes de Oca LR, Pena JR, Lozano G. Mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts. Oncogene 1996; 13: 1731-1736. (Pubitemid 26377505)
40. Nielsen R, Grontved L, Stunnenberg HG, Mandrup S. Peroxisome proliferator-activated receptor subtype-and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery. Mol Cell Biol 2006; 26: 5698-5714. (Pubitemid 44134327)
41. Madsen L, Petersen RK, Sorensen MB, Jorgensen C, Hallenborg P, Pridal L et al. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipooxygenase activity during the initial stages of the differentiation process. Biochem J 2003; 375: 539-549. (Pubitemid 37433502)